AI Article Synopsis
- A study was conducted to test the effectiveness of 12 lateral flow devices for detecting the SARS-CoV-2 variant BA.2.86.
- Devices from ACON, Orient Gene, Xiamen Biotime, Getein, and SureScreen demonstrated good sensitivity in identifying this variant, similar to previous Omicron variants.
- The UK government's existing stock of lateral flow devices is adequate for use with this variant and does not require replacement.
Article Abstract
We evaluated the performance of 12 lateral flow devices by assessing their analytical sensitivity for SARS-CoV-2 variant BA.2.86. Kits from ACON, Orient Gene, Xiamen Biotime, Getein, and SureScreen detected variant BA.2.86 to sufficient sensitivity levels, comparable to those observed with previous Omicron variants. The stocks of lateral flow devices currently held by the UK government do not currently need changing for deployment for this variant.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ijid.2023.12.010 | DOI Listing |
Publication Analysis
Top Keywords
lateral flow
12
flow devices
12
variant ba286
8
detection sars-cov-2
4
sars-cov-2 ba286
4
ba286 lateral
4
devices evaluated
4
evaluated performance
4
performance lateral
4
devices assessing
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!